J. Krueger

A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis

K. Papp, G. Ball, J. Krueger, 2015, The British journal of dermatology.

A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

A. Gottlieb, K. Papp, K. Reich, 2016, The British journal of dermatology.

Dust mite induces multiple polar T cell axes in human skin

M. Suárez-Fariñas, B. Ungar, S. Garcet, 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

479 Distinct patterns of gene expression in skin biopsies differentiate generalized pustular psoriasis (GPP) from psoriasis vulgaris (PV)

S. Garcet, H. Bachelez, S. Visvanathan, 2022, Journal of Investigative Dermatology.

Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.

A. Gottlieb, J. Krueger, D. Carter, 1990 .

Tildrakizumab (MK‐3222), an anti‐interleukin‐23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo‐controlled trial

A. Gottlieb, H. Nakagawa, K. Papp, 2015, The British journal of dermatology.

Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐blind multicentre study

S. Garcet, B. Dizier, D. Baeten, 2021, The British journal of dermatology.

Skin microbiome and its association with host cofactors in determining atopic dermatitis severity

P. Brunner, E. Guttman‐Yassky, C. Traidl‐Hoffmann, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Identification of unique proteomic signatures in allergic and non‐allergic skin disease

M. Suárez-Fariñas, E. Guttman‐Yassky, Y. Estrada, 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Intrinsic atopic dermatitis ( AD ) shows similar Th 2 and higher Th 17 immune activation compared to extrinsic AD

M. Suárez-Fariñas, C. G. Strong, I. Cardinale, 2014 .

Increased expression of IL‐17A and limited involvement of IL‐23 in patients with palmo‐plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial

R. Bissonnette, C. Lynde, R. Langley, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.